Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)

Yusuke Matoba, Iori Kisu, Asako Sera, Megumi Yanokura, Kouji Banno, Daisuke Aoki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been developed and applied clinically over recent years; however, whole solid organs still cannot be produced. Though uterine regeneration has the potential to be a treatment for AUFI, there have been only a few studies on uterine regeneration involving the myome-trium in vivo. In the present report, those relevant articles are reviewed. A literature search was conducted in PubMed with a combination of key words, and 10 articles were found, including nine in rat models and one in a mouse model. Of these studies, eight used scaffolds and two were performed without scaffolds. In four of these studies, scaffolds were re-cellularized with various cells. In the remaining four studies, scaffolds were transplanted alone, or other structures were used. Though the methods differed, the injured uterus recovered well, morphologically and functionally, in every study. Only 10 articles were relevant to our investigation, but the results were favorable, if limited to partial regeneration. Recently, uterus transplantation (UTx) has been investigated as a treatment for AUFI. However, UTx has many problems in the medical, ethical and social fields. Though the artificial uterus was also researched and some improvements in this technology were reported, it will take long time for this to reach a clinically applicable stage. Though the results of uterine regeneration studies were promising, these studies were conducted using animal models, so further human studies and trials are needed.

Original languageEnglish
Pages (from-to)79-86
Number of pages8
JournalBiomedical Reports
Volume10
Issue number2
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Regenerative Medicine
Scaffolds
Infertility
Uterus
Regeneration
Technology
PubMed
Reproduction
Rats
Animals
Animal Models
Transplantation
Defects

Keywords

  • Absolute uterine factor infertility
  • Bioengineering
  • Mayer-Rokitansky-Küster-Hauser syndrome
  • Tissue engineering
  • Uterine regeneration

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Current status of uterine regenerative medicine for absolute uterine factor infertility (Review). / Matoba, Yusuke; Kisu, Iori; Sera, Asako; Yanokura, Megumi; Banno, Kouji; Aoki, Daisuke.

In: Biomedical Reports, Vol. 10, No. 2, 01.01.2019, p. 79-86.

Research output: Contribution to journalArticle

Matoba, Yusuke ; Kisu, Iori ; Sera, Asako ; Yanokura, Megumi ; Banno, Kouji ; Aoki, Daisuke. / Current status of uterine regenerative medicine for absolute uterine factor infertility (Review). In: Biomedical Reports. 2019 ; Vol. 10, No. 2. pp. 79-86.
@article{5ed87234f37646ceade1df9b1a6ff8b7,
title = "Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)",
abstract = "Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been developed and applied clinically over recent years; however, whole solid organs still cannot be produced. Though uterine regeneration has the potential to be a treatment for AUFI, there have been only a few studies on uterine regeneration involving the myome-trium in vivo. In the present report, those relevant articles are reviewed. A literature search was conducted in PubMed with a combination of key words, and 10 articles were found, including nine in rat models and one in a mouse model. Of these studies, eight used scaffolds and two were performed without scaffolds. In four of these studies, scaffolds were re-cellularized with various cells. In the remaining four studies, scaffolds were transplanted alone, or other structures were used. Though the methods differed, the injured uterus recovered well, morphologically and functionally, in every study. Only 10 articles were relevant to our investigation, but the results were favorable, if limited to partial regeneration. Recently, uterus transplantation (UTx) has been investigated as a treatment for AUFI. However, UTx has many problems in the medical, ethical and social fields. Though the artificial uterus was also researched and some improvements in this technology were reported, it will take long time for this to reach a clinically applicable stage. Though the results of uterine regeneration studies were promising, these studies were conducted using animal models, so further human studies and trials are needed.",
keywords = "Absolute uterine factor infertility, Bioengineering, Mayer-Rokitansky-K{\"u}ster-Hauser syndrome, Tissue engineering, Uterine regeneration",
author = "Yusuke Matoba and Iori Kisu and Asako Sera and Megumi Yanokura and Kouji Banno and Daisuke Aoki",
year = "2019",
month = "1",
day = "1",
doi = "10.3892/br.2019.1182",
language = "English",
volume = "10",
pages = "79--86",
journal = "Biomedical Reports",
issn = "2049-9434",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)

AU - Matoba, Yusuke

AU - Kisu, Iori

AU - Sera, Asako

AU - Yanokura, Megumi

AU - Banno, Kouji

AU - Aoki, Daisuke

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been developed and applied clinically over recent years; however, whole solid organs still cannot be produced. Though uterine regeneration has the potential to be a treatment for AUFI, there have been only a few studies on uterine regeneration involving the myome-trium in vivo. In the present report, those relevant articles are reviewed. A literature search was conducted in PubMed with a combination of key words, and 10 articles were found, including nine in rat models and one in a mouse model. Of these studies, eight used scaffolds and two were performed without scaffolds. In four of these studies, scaffolds were re-cellularized with various cells. In the remaining four studies, scaffolds were transplanted alone, or other structures were used. Though the methods differed, the injured uterus recovered well, morphologically and functionally, in every study. Only 10 articles were relevant to our investigation, but the results were favorable, if limited to partial regeneration. Recently, uterus transplantation (UTx) has been investigated as a treatment for AUFI. However, UTx has many problems in the medical, ethical and social fields. Though the artificial uterus was also researched and some improvements in this technology were reported, it will take long time for this to reach a clinically applicable stage. Though the results of uterine regeneration studies were promising, these studies were conducted using animal models, so further human studies and trials are needed.

AB - Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been developed and applied clinically over recent years; however, whole solid organs still cannot be produced. Though uterine regeneration has the potential to be a treatment for AUFI, there have been only a few studies on uterine regeneration involving the myome-trium in vivo. In the present report, those relevant articles are reviewed. A literature search was conducted in PubMed with a combination of key words, and 10 articles were found, including nine in rat models and one in a mouse model. Of these studies, eight used scaffolds and two were performed without scaffolds. In four of these studies, scaffolds were re-cellularized with various cells. In the remaining four studies, scaffolds were transplanted alone, or other structures were used. Though the methods differed, the injured uterus recovered well, morphologically and functionally, in every study. Only 10 articles were relevant to our investigation, but the results were favorable, if limited to partial regeneration. Recently, uterus transplantation (UTx) has been investigated as a treatment for AUFI. However, UTx has many problems in the medical, ethical and social fields. Though the artificial uterus was also researched and some improvements in this technology were reported, it will take long time for this to reach a clinically applicable stage. Though the results of uterine regeneration studies were promising, these studies were conducted using animal models, so further human studies and trials are needed.

KW - Absolute uterine factor infertility

KW - Bioengineering

KW - Mayer-Rokitansky-Küster-Hauser syndrome

KW - Tissue engineering

KW - Uterine regeneration

UR - http://www.scopus.com/inward/record.url?scp=85059659702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059659702&partnerID=8YFLogxK

U2 - 10.3892/br.2019.1182

DO - 10.3892/br.2019.1182

M3 - Article

AN - SCOPUS:85059659702

VL - 10

SP - 79

EP - 86

JO - Biomedical Reports

JF - Biomedical Reports

SN - 2049-9434

IS - 2

ER -